Links

Shuji Ogino (Ogino, Shuji) websites in other places
Blog (in Japanese): https://www.ogino-mpe.org/
The MPE Lab page at the DFCI website: http://ogino-mpe-lab.dana-farber.org/
Program in MPE Molecular Pathological Epidemiology, Brigham and Women’s Hospital
https://www.brighamandwomens.org/pathology/research/program-in-molecular-pathological-epidemiology
(Japanese)
Collaborators (selected list.  I cannot list all of collaborators in the past and present.  This limited space requires a selection of people.  Nonetheless, I appreciate all of collaborations!  You can see a wide range of experts in diverse fields from basic science to population science)
Charles S. Fuchs, MD, MPH, Director of Yale Cancer Center, Physician-in-Chief of Smilow Cancer Hospital at Yale New Haven, Professor at Yale School of Medicine
Andrew T. Chan, MD, MPH, Massachusetts General Hospital, Director of Clinical and Translational Epidemiology Unit, Director of Gastroenterology Training Program
Edward Giovannucci, MD, MPH, ScD, Harvard T.H. Chan School of Public Health
(Alphabetical order from here)
David A. Barbie, MD, Dana-Farber Cancer Institute
Adam Bass, MD, Dana-Farber Cancer Institute
Andrew H. Beck, MD, PhD, Beth Israel Deaconess Medical Center
Monica M. Bertagnolli, MD, Brigham and Women’s Hospital
Carlos A. Camargo, Jr. MD, DrPH, Massachusetts General Hospital
Fernando Camargo, PhD, Harvard Stem Cell Institute, Children’s Hospital Boston
Peter T. Campbell, PhD, American Cancer Society
Lewis C. Cantley, PhD, Weill Cornell Medical College
Jennifer A. Chan, MD, Dana-Farber Cancer Institute
Eunyoung Cho, ScD, Brown University
David C. Christiani, MD, MPH, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital
Daniel C. Chung, MD, Massachusetts General Hospital
George Q. Daley, MD, PhD, Children’s Hospital Boston, Director of the Stem Cell Transplantation Program
Dora Dias-Santagata, PhD, Massachusetts General Hospital
Glenn Dranoff, MD, Dana-Farber Cancer Institute, Co-Director of Cancer Vaccine Center
Jeffrey A. Engelman, MD, PhD, Massachusetts General Hospital
Alison E. Field, ScD, Children’s Hospital Boston
Ron Firestein, MD, PhD, Genentech
David A. Frank, MD, PhD, Dana-Farber Cancer Institute
Jerome Galon, PhD, INSERM
Levi A. Garraway, MD, Dana-Farber Cancer Institute, The Broad Institute
Wendy S. Garrett, MD, PhD, Harvard T.H. Chan School of Public Health
Marios Giannakis, MD, PhD, Dana-Farber Cancer Institute, The Broad Institute
Ajay Goel, PhD, Baylor University Medical Center
Wolfram Goessling, MD, PhD, Harvard Stem Cell Institute
Todd R. Golub, MD, The Broad Institute, Director of Cancer Program
Michael Green, MD, PhD, University of Massachusetts
Wayne W. Grody, MD, PhD, UCLA
William C. Hahn, MD, PhD, Dana-Farber Cancer Institute, Chief of Division of Molecular and Cellular Oncology
Kevin M. Haigis, PhD, Massachusetts General Hospital
Curtis C. Harris, MD, National Cancer Institute, National Institute of Health
Richard O. Haynes, PhD, Koch Institute for Integrative Cancer Research, MIT
Aditi Hazra, PhD, MPH, Brigham and Women’s Hospital
Jason L. Hornick, MD, PhD, Brigham and Women’s Hospital
Yujin Hoshida, MD, Mount Sinai Medical School
Frank B. Hu, MD, PhD, Harvard T.H. Chan School of Public Health
Kenneth Hung,
David J. Hunter, MBBS, ScD, Harvard T.H. Chan School of Public Health, Dean for Academic Affairs
Curtis Huttenhower, PhD, Harvard T.H. Chan School of Public Health
Anthony John Iafrate, MD, PhD, Massachusetts General Hospital
Rudolf Jaenisch, MD, Whitehead Institute, MIT
Ichiro Kawachi, MD, PhD, Harvard T.H. Chan School of Public Health, Chair of Department of Social and Behavioral Sciences
Hamed Khalili, MD, Massachusetts General Hospital
Peter Kraft, PhD, Harvard T.H. Chan School of Public Health, Director of Program in Quantitative Genomics (PQG)
Matthew H. Kulke, MD, MMSc, Dana-Farber Cancer Institute, Director of Program in Neuroendocrine and Carcinoid Tumors
Raju Kucherlapati, PhD, Harvard Medical School
Peter W. Laird, PhD, University of Southern California
Jung Eun Lee, ScD, Sookmyung Women’s University
Barbara Leggett, MD, Queensland Institute of Medical Research, Head of Conjoint Gastroenterology Laboratory
Debra Leonard, MD, PhD, University of Vermont, Chair of Department of Pathology
Neal I. Lindeman, MD, Brigham and Women’s Hospital, Director of Molecular Diagnostics Laboratory
Paul Lochhead, MBChB, MRCP, University of Aberdeen
Massimo Loda, MD, Chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and Pathologist-in-Chief at New York-Presbyterian/Weill Cornell Medical Center
Janina A. Longtine, MD, Icahn School of Medicine at Mount Sinai
Umar Mahmood, MD, PhD, Massachusetts General Hospital
G. Mike Makrigiorgos, PhD, Dana-Farber Cancer Institute
Sanford D. Markowitz, MD, PhD, Case Western Reserve University
Alexander Meisser, PhD, The Broad Institute, Harvard University
Jeffrey A. Meyerhardt, MD, MPH, Dana-Farber Cancer Institute, Clinical Director of Gastrointestinal Cancer Center
Matthew Meyerson, MD, PhD, Dana-Farber Cancer Institute, The Broad Institute
Danny A. Milner, MD, MS, Brigham and Women’s Hospital
Mari Mino-Kenudson, MD, Massachusetts General Hospital
George F. Murphy, MD, Brigham and Women’s Hospital
Hongmei Nan, MD, PhD, Indiana Univerisity
Polly A. Newcomb, PhD, MPH, Fred Hutchinson Cancer Research Center
Kimmie Ng, MD, MPH, Dana-Farber Cancer Institute
Katsuhiko Nosho, MD, PhD, Sapporo Medical University
Jukka-Pekka Onnela, DSc, Harvard School of Public Health
Giovanni Parmigiani, PhD, Dana-Farber Cancer Institute, Chair of Department of Biostatistics and Computational Biology
Ulrike Peters, PhD, Fred Hutchinson Cancer Research Center, PI of GECCO (Genetics and Epidemiology of Colorectal Cancer Consortium)
Amanda I. Phipps, PhD, Fred Hutchinson Cancer Research Center
Michael N. Pollak, MD, McGill University
John Quackenbush, PhD, Dana-Farber Cancer Institute, Director of Center for Cancer Computational Biology (CCCB)
Bernard A. Rosner, PhD, Harvard T.H. Chan School of Public Health
Eva S. Schernhammer, MD, DrPH, Brigham and Women’s Hospital
Deborah Schrag, MD, MPH, Dana-Farber Cancer Institute, Chief of Division of Population Sciences
Mark E. Sherman, MD, National Cancer Institute, National Institute of Health
Ramesh A. Shivdasani, MD, PhD, Dana-Farber Cancer Institute
David A. Sinclair, PhD, Harvard Medical School
Stephanie A. Smith-Warner, PhD, Harvard T.H. Chan School of Public Health
Donna Spiegelman, ScD, Harvard T.H. Chan School of Public Health
Meir J. Stampfer, MD, DrPH, Brigham and Women’s Hospital, Associate Director of Channing Division of Network Medicine
Andy S. Tan, PhD, MPH, MBA, MBBS, Dana-Farber Cancer Institute
Sarah P Thayer, MD, PhD, Massachusetts General Hospital
Matthew Vander Heiden, MD, PhD, Koch Institute for Integrative Cancer Research, MIT
Tyler J. VanderWeele, PhD, Harvard T.H. Chan School of Public Health
Molin Wang, PhD, Harvard T.H. Chan School of Public Health
Vicki Whitehall, PhD, Queensland Institute of Medical Research
Walter C. Willett, MD, DrPH, Harvard T.H. Chan School of Public Health, Chair of Department of Nutrition
Michelle A. Williams, ScD, Harvard T.H. Chan School of Public Health, Chair of Department of Epidemiology
Robert B. Wilson, MD, PhD, University of Pennsylvania
Brian M. Wolpin, MD, MPH, Dana-Farber Cancer Institute
(Cohorts, Trials, Consortia)
Health Professionals Follow-up Study (HPFS) (PI, Dr. Walter C. Willett)
Nurses’ Health Study (NHS) (Past and Current PIs; Drs. Frank Speizer, Graham Colditz, Susan E. Hankinson, Meir J. Stampfer)
Nurses’ Health Study II (NHS2) (PI, Dr. Walter C. Willett)
Alliance for Clinical Trials in Oncology (Chair, Dr. Monica M. Bertagnolli)
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) (PI, Dr. Ulrike Peters)
GAME-ON Epigenetics Working Group (Chair, Dr. Cornelia (Neli) Ulrich)
Pooling Project of Prospective Studies of Diet and Cancer (PI, Dr. Stephanie A. Smith-Warner)